Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies
Completed · Phase 1 · Has a placebo group
Conditions studied: Allergies, Allergic Rhinitis, Asthma
In brief
This is a study for children and adults who are interested in a new therapy for their allergies to dust mite and timothy grass. The new therapy is called sublingual immunotherapy and the investigators are testing if it is safe and well tolerated.
Key facts
- Study ID
- NCT01529437
- Run by
- Stanford University
- People needed
- 31
- Starts
- 2005-01-01
- Expected to finish
- 2014-01-01
- Last updated by the study team
- 2015-11-26
Who can join
Age: 5 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.